N. Chalasani

Epidemiology · 2008–2021

A researcher in the Science corpus: 11 papers; trusts 3 researchers and is trusted by 2 researchers here, as inferred from the citation graph.

Subfields

Whom N. Chalasani trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. J. Schwimmer
  2. Z. Younossi
  3. B. Neuschwander‐Tetri
  4. Jordi Bruix1 , 2
  5. A. Sanyal
  6. J. Lavine
  7. E. Bugianesi
  8. D. Kleiner
  9. Sarah E. Barlow
  10. S. Harrison

Who trusts N. Chalasani overall

  1. Z. Younossi
  2. G. Targher
  3. V. Ratziu
  4. M. Rinella
  5. K. Cusi
  6. Herbert Tilg
  7. Christopher D. Byrne
  8. Y. Sumida
  9. Megan H. Bair-Merritt
  10. S. Friedman

Papers from N. Chalasani's perspective

Ordered by how strongly the researchers N. Chalasani trusts endorse each paper. Same corpus, a different order for every researcher.

  1. ENDPOINTS AND CLINICAL TRIAL DESIGN FOR NONALCOHOLIC STEATOHEPATITIS (Hepatology)
  2. Long‐term follow‐up of patients with NAFLD and elevated liver enzymes (Hepatology)
  3. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. (Gastroenterology)
  4. Design and validation of a histological scoring system for nonalcoholic fatty liver disease (Hepatology)
  5. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome (Hepatology)
  6. Liver Fibrosis, but no Other Histologic Features, Associates with Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease (Gastroenterology)
  7. The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the… (American Journal of Gastroenterology)
  8. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. (New England Journal of Medicine)
  9. Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity (Annals medicus)
  10. Meta‐analysis of the influence of I148M variant of patatin‐like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease (Hepatology)

Their papers